アスピリンの世界市場レポート 2025年

アスピリンの市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）6.0％で33億8,000万米ドルに成長します。予測期間における成長は、慢性疾患の罹患率の上昇、神経疾患における有益性の可能性、製薬業界の革新、発展途上地域における採用の増加、セルフケアの人気の高まりなどに起因すると考えられます。予測期間の主な動向には、がん予防研究、併用療法、個別化医療アプローチ、カスタマイズされた剤形とデリバリーシステム、遠隔医療、セルフケアなどがあります。

関節炎の罹患率の上昇が、今後数年間のアスピリン市場の成長を牽引すると予測されます。関節炎は、関節の痛みや腫れを特徴とする病状です。非ステロイド性抗炎症薬であるアスピリンは、炎症を和らげ、痛みを軽減し、機能性を向上させることで、関節炎やその他の病気による慢性的な痛みを持つ人々を助けます。関節炎患者の増加は、アスピリンの使用量の増加と直接相関しています。例えば、2023年11月、英国の政府機関である安全衛生庁（HSE）は、2022年から2023年の間に、労働関連の筋骨格系障害に苦しむ労働者の総数は47万3,000人に達し、労働者10万人当たりの有病率は1,400人であったと報告しました。さらに、新規症例は13万2,000人で、これは労働者10万人当たり390人の発生率を示しています。その結果、関節炎の有病率の増加がアスピリン市場の拡大に拍車をかけています。

心血管疾患の世界的な増加は、今後アスピリン市場の成長をさらに促進すると予想されます。心血管疾患には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。アスピリンは、心血管疾患、特に心臓発作や脳卒中のリスクのある個人の予防策として頻繁に推奨されています。例えば、2024年5月、シンガポールを拠点とする非営利団体であるシンガポール心臓財団（SHF）は、虚血性心疾患により5,302人が亡くなり、2022年の5,290人からわずかに増加したと報告しました。したがって、世界的な心血管疾患の増加が、アスピリン市場を牽引すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のアスピリン市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアスピリン市場：成長率分析
• 世界のアスピリン市場の実績：規模と成長、2019～2024年
• 世界のアスピリン市場の予測：規模と成長、2024～2029年、2034年
• 世界のアスピリン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアスピリン市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 処方箋
• OTC
• 世界のアスピリン市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 直腸
• 非経口
• 世界のアスピリン市場：剤形別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• 注射
• 坐薬
• 世界のアスピリン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 心血管疾患
• 痛み、発熱、炎症
• その他の用途
• 世界のアスピリン市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• その他
• 世界のアスピリン市場：処方薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 低用量アスピリン（81mg）
• 高用量アスピリン（325 mg）
• 世界のアスピリン市場：OTC（市販薬）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• レギュラーストレングスアスピリン（325mg）
• エクストラストレングスアスピリン（500mg）
• 緩衝アスピリン
• アスピリン配合剤

第7章 地域別・国別分析

• 世界のアスピリン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のアスピリン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アスピリン市場：競合情勢
• アスピリン市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Allegiant Health Overview, Products and Services, Strategy and Financial Analysis
  • Par Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Nanjing pharmaceutical factory Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• JQC（Huayin）Pharmaceutical Co. Ltd.
• LNK International Inc.
• Bal Pharma Limited
• Trumac Healthcare
• Perrigo Company PLC
• Alta Laboratories Ltd.
• Zhenjiang Gaopeng Pharmaceutical Co. Ltd.
• J.M. Loveridge Ltd.
• Mayne Pharma Group Limited
• St. Joseph's Aspirin
• Teva Pharmaceutical Industries Ltd
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Ltd.
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アスピリン市場2029年：新たな機会を提供する国
• アスピリン市場2029年：新たな機会を提供するセグメント
• アスピリン市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Aspirin, also known as acetylsalicylic acid (ASA), is a non-steroidal anti-inflammatory drug used to treat fever and minor aches. It is employed for conditions such as arthritis and to mitigate the risk of issues such as heart attacks and strokes.

There are two primary types of aspirin products such as prescription and over-the-counter (OTC). Prescription drugs can only be obtained with a certified physician's prescription. As for the route of administration, aspirin comes in oral, rectal, and parenteral forms. Various dosage forms include tablets, capsules, injections, and suppositories. Aspirin finds applications in diverse areas, including cardiovascular disease, pain relief, fever reduction, inflammation management, among others. It is utilized by a range of end-users, such as hospitals, clinics, and other healthcare facilities.

The aspirin market research report is one of a series of new reports from The Business Research Company that provides aspirin market statistics, including aspirin industry global market size, regional shares, competitors with a aspirin market share, detailed aspirin market segments, market trends and opportunities, and any further data you may need to thrive in the aspirin industry. This aspirin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aspirin market size has grown steadily in recent years. It will grow from $2.56 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to pain management and analgesic demand, cardiovascular health awareness, anti-inflammatory properties, preventive measures for stroke and heart attacks, treatment of fever and headaches, rheumatic fever and arthritis treatment.

The aspirin market size is expected to see strong growth in the next few years. It will grow to $3.38 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising incidence of chronic diseases, potential benefits in neurological disorders, pharmaceutical industry innovations, increased adoption in developing regions, growing popularity of self-care practices. Major trends in the forecast period include cancer prevention research, combination therapies, personalized medicine approaches, customized dosage forms and delivery systems, telemedicine and self-care.

The rising incidence of arthritis is projected to drive the growth of the aspirin market in the coming years. Arthritis is a medical condition characterized by pain and swelling in the joints. Aspirin, a nonsteroidal anti-inflammatory drug, aids individuals with chronic pain from arthritis and other ailments by alleviating inflammation, reducing pain, and enhancing functionality. An increase in arthritis cases directly correlates with higher aspirin usage. For example, in November 2023, the Health and Safety Executive (HSE), a UK government agency, reported that the total number of workers suffering from work-related musculoskeletal disorders reached 473,000 during the 2022-2023 period, reflecting a prevalence rate of 1,400 per 100,000 workers. Additionally, there were 132,000 new cases, indicating an incidence rate of 390 per 100,000 workers. Consequently, the growing prevalence of arthritis is fueling the expansion of the aspirin market.

The significant global burden of cardiovascular diseases is expected to further propel the growth of the aspirin market in the future. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels. Aspirin is frequently recommended as a preventive measure for cardiovascular diseases, especially for individuals at risk of heart attacks or strokes. For instance, in May 2024, the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, reported that ischemic heart diseases accounted for 5,302 deaths, reflecting a slight increase from 5,290 deaths in 2022. Therefore, the substantial burden of cardiovascular diseases worldwide is anticipated to drive the aspirin market.

Major companies in the aspirin market are increasingly adopting a strategic partnership approach to enhance technology integration and broaden their market reach. A strategic partnership generally involves a collaborative relationship between two or more organizations, where they combine their resources, expertise, and efforts to achieve shared goals. For example, in February 2023, Huma Therapeutics Limited (Huma), a digital health company based in the UK, collaborated with Bayer AG, a Germany-based life sciences firm, to launch the Bayer Aspirin Heart Risk Assessment online tool. This tool helps users identify their risk factors for developing cardiovascular disease over the next decade and enables them to share their results with their healthcare providers. Huma has created an algorithm that predicts long-term cardiovascular disease risk using data from the UK Biobank. Individuals can access the Heart Risk Assessment tool on the Bayer Aspirin website, where they will find a user-friendly questionnaire containing 15 questions. Based on their answers, the tool evaluates whether they are at higher, average, or lower risk of developing cardiovascular disease by comparing their responses to data from the research population.

In May 2024, Sun Pharmaceutical Industries Ltd., a specialty generic pharmaceutical company based in India, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. This acquisition is intended to enhance Sun Pharma's presence in the pharmaceutical market, particularly in segments like off-patent pharmaceuticals, prescription medications, and over-the-counter products. Taro Pharmaceutical Industries Ltd., located in Israel, is a research-focused pharmaceutical manufacturer known for producing acetylsalicylic acid capsules.

In March 2022, Advent International Corporation, a US-based investment firm, acquired the over-the-counter (OTC) and pharmaceutical businesses in Mexico and Brazil from Perrigo Company plc for an undisclosed amount. This acquisition allows Advent to expand its regional investment strategy within the healthcare sector, drawing on over twenty years of industry experience to strengthen its market position. Perrigo Company plc is an Ireland-based manufacturer of pharmaceutical products, including aspirin tablets.

Major companies operating in the aspirin market include Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co. Ltd., LNK International Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co. Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited, St. Joseph's Aspirin, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Hetero Labs Ltd., Jubilant Generics Ltd., Lupin Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd.

Asia-Pacific was the largest region in the aspirin market in 2024. The regions covered in the aspirin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the aspirin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aspirin market consists of sales of capsules, chewable, and coated tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aspirin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aspirin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aspirin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aspirin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Prescription; OTC
• 2) By Route Of Administration: Oral; Rectal; Parenteral
• 3) By Dosage Form: Tablets; Capsules; Injections; Suppositories
• 4) By Application: Cardiovascular Disease; Pain, Fever, O Inflammation; Other Applications
• 5) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Prescription Aspirin: Low-Dose Aspirin (81 Mg); High-Dose Aspirin (325 Mg)
• 2) By OTC (Over-the-Counter) Aspirin: Regular Strength Aspirin (325 Mg); Extra-Strength Aspirin (500 Mg); Buffered Aspirin; Aspirin Combinations
• Companies Mentioned: Bayer AG; Allegiant Health; Par Pharmaceutical; Cardinal Health Inc.; Nanjing pharmaceutical factory Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aspirin Market Characteristics

3. Aspirin Market Trends And Strategies

4. Aspirin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Aspirin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Aspirin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Aspirin Market Growth Rate Analysis
• 5.4. Global Aspirin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Aspirin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Aspirin Total Addressable Market (TAM)

6. Aspirin Market Segmentation

• 6.1. Global Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription
• OTC
• 6.2. Global Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Rectal
• Parenteral
• 6.3. Global Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injections
• Suppositories
• 6.4. Global Aspirin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Disease
• Pain, Fever, O Inflammation
• Other Applications
• 6.5. Global Aspirin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.6. Global Aspirin Market, Sub-Segmentation Of Prescription Aspirin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose Aspirin (81 Mg)
• High-Dose Aspirin (325 Mg)
• 6.7. Global Aspirin Market, Sub-Segmentation Of OTC (Over-the-Counter) Aspirin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regular Strength Aspirin (325 Mg)
• Extra-Strength Aspirin (500 Mg)
• Buffered Aspirin
• Aspirin Combinations

7. Aspirin Market Regional And Country Analysis

• 7.1. Global Aspirin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Aspirin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aspirin Market

• 8.1. Asia-Pacific Aspirin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aspirin Market

• 9.1. China Aspirin Market Overview
• 9.2. China Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aspirin Market

• 10.1. India Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aspirin Market

• 11.1. Japan Aspirin Market Overview
• 11.2. Japan Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aspirin Market

• 12.1. Australia Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aspirin Market

• 13.1. Indonesia Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aspirin Market

• 14.1. South Korea Aspirin Market Overview
• 14.2. South Korea Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aspirin Market

• 15.1. Western Europe Aspirin Market Overview
• 15.2. Western Europe Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aspirin Market

• 16.1. UK Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aspirin Market

• 17.1. Germany Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aspirin Market

• 18.1. France Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aspirin Market

• 19.1. Italy Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aspirin Market

• 20.1. Spain Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aspirin Market

• 21.1. Eastern Europe Aspirin Market Overview
• 21.2. Eastern Europe Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aspirin Market

• 22.1. Russia Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aspirin Market

• 23.1. North America Aspirin Market Overview
• 23.2. North America Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aspirin Market

• 24.1. USA Aspirin Market Overview
• 24.2. USA Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aspirin Market

• 25.1. Canada Aspirin Market Overview
• 25.2. Canada Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aspirin Market

• 26.1. South America Aspirin Market Overview
• 26.2. South America Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aspirin Market

• 27.1. Brazil Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aspirin Market

• 28.1. Middle East Aspirin Market Overview
• 28.2. Middle East Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aspirin Market

• 29.1. Africa Aspirin Market Overview
• 29.2. Africa Aspirin Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Aspirin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Aspirin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aspirin Market Competitive Landscape And Company Profiles

• 30.1. Aspirin Market Competitive Landscape
• 30.2. Aspirin Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Allegiant Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Par Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Nanjing pharmaceutical factory Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Aspirin Market Other Major And Innovative Companies

• 31.1. JQC (Huayin) Pharmaceutical Co. Ltd.
• 31.2. LNK International Inc.
• 31.3. Bal Pharma Limited
• 31.4. Trumac Healthcare
• 31.5. Perrigo Company PLC
• 31.6. Alta Laboratories Ltd.
• 31.7. Zhenjiang Gaopeng Pharmaceutical Co. Ltd.
• 31.8. J.M. Loveridge Ltd.
• 31.9. Mayne Pharma Group Limited
• 31.10. St. Joseph's Aspirin
• 31.11. Teva Pharmaceutical Industries Ltd
• 31.12. Boehringer Ingelheim International GmbH
• 31.13. Cadila Healthcare Ltd.
• 31.14. Cipla Ltd.
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Aspirin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aspirin Market

34. Recent Developments In The Aspirin Market

35. Aspirin Market High Potential Countries, Segments and Strategies

• 35.1 Aspirin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Aspirin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Aspirin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer